Atlas Trials

A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis

Clinical trial NCT01363388 · COMPLETED

Trial details

NCT number
NCT01363388
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Vasculitis
Start date
2011-09-01
Primary completion
2015-10-01
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.